Friday, April 19, 2019
Thursday, April 18, 2019
"To identify age-related patterns of events that could have or did result in unanticipated patient harm, the Pennsylvania Patient Safety Authority developed a data snapshot from more than 260,000 event reports submitted by Pennsylvania hospitals through the Pennsylvania Patient Safety Reporting System during 2017. For almost all age cohorts, the most common event type was Error related to Procedure/Treatment/Test while among Serious Event reports (i.e., event resulting in harm), the most common event type was Complication of Procedure/Treatment/Test.
Differences in event report patterns for children, adolescents, and young adults compared with events involving adults and elderly patients were noted. For adults 75 years or older, the number of event reports decreased, while the rate of involvement in a patient safety event report relative to estimated population increased as patient age increased. For adults 25 years or older, the number of reports involving two event types—Fall and Skin Integrity—increased with advancing age. Although the increased rate of total event reports at the extremes of age relative to estimated population was unsurprising, the decreased rate of Serious Events in the very elderly, and the increased rate of total and Serious Events in the age cohort of 5 to 14 years relative to number of admissions were unanticipated.
Attention to the event types and patterns of vulnerability that predominate in specific age cohorts may help facilities prioritize interventions."
Posted by SNi at 4/18/2019 07:30:00 PM
Saturday, April 13, 2019
"The cost of medical device innovation: can we keep pace?© 2019 Vizient, Inc. All rights reserved.The cost of medical device innovation: can we keep pace?Innovation is the hallmark of U.S. health care. Over the last decade, advances in medical device technology have had an extraordinary positive impact on patient outcomes and quality of life. In 2017, the number of first-time premarket approvals by the U.S. Food and Drug Administration (FDA) increased 28 percent from the previous year, while the number of 510(k) clearances was up 9 percent.
While these novel devices may provide advanced treatment options, improved quality of life and extended longevity for patients, the high costs associated with the devices and procedures create challenges for hospitals. Because of high research and development costs, the expense of clinical trials and market factors, an innovative medical device almost always carries a premium price. A review of several recent innovative cardiovascular medical device introductions reveals an average 273.3 percent increase in price (range, 163 percent to 565 percent; Table 1) over the predicate medical device.."
Posted by SNi at 4/13/2019 10:01:00 AM
Wednesday, April 3, 2019
Source: Global Progress on Shark, Ray CITES Listings
"Each year, at least 63 million and as many as 273 million sharks are killed in the world’s commercial fisheries, an unsustainable fishing rate driven by increasing demand for their fins, meat, liver oil, and other products.1 As a result, shark populations have suffered declines worldwide, and more than half of shark species and their relatives assessed by the International Union for Conservation of Nature are categorized as Threatened or Near Threatened with extinction."
Posted by SNi at 4/03/2019 10:46:00 PM